1. Biomarkers associated with anastomotic leakage after esophagectomy: a systematic review.
- Author
-
Popa, Călin, Schlanger, Diana, Aiolfi, Alberto, ElShafei, Moustafa, Triantafyllou, Tania, Theodorou, Dimitrios, Skrobic, Ognjan, Simic, Aleksandar, Al Hajjar, Nadim, and Bonavina, Luigi
- Subjects
- *
NEOADJUVANT chemotherapy , *MEDICAL sciences , *ESOPHAGECTOMY , *STATISTICAL significance , *BIOMARKERS - Abstract
Purpose: Anastomotic leakage (AL) is one of the most important complications that occurs after upper gastrointestinal surgery, registering rates of 20–30% after esophagectomy. The role of systemic inflammatory biomarkers to predict anastomotic leaks is controversial and needs systematization. Methods: A systematic review based on the PRISMA guidelines criteria was performed. PubMed, Scopus, and Embase were queried using MESH Terms and All Fields key words to identify studies investigating a range of immune-inflammatory factors in predicting AL. Results: Twenty-four studies were included in this review. The total number of included patients was 5903, ranging in each study from 42 to 612. The included studies reported patients that underwent different techniques of esophagectomy (Ivor Lewis, McKeown, Orringer or thoracoabdominal esophagectomy) and 23 out of 24 studies included patients that underwent neoadjuvant treatment. While different biomarkers at different timepoints were analyzed, most studies have indicated postoperative biomarkers, between day 3 and day 5 to reach statistical significance. Conclusions: Systemic inflammatory biomarkers represent potential risk stratification and predicting tools for AL after esophageal surgery, but more studies need to be conducted to validate their clinical utility. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF